Controlled Release Of Medication - Pharma

Relevant Publications

Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis.

Issue Release: 2024

Formulation and clinical evaluation of carbidopa/levodopa oral solution for the treatment of sepiapterin reductase deficiency.

Issue Release: 2024

Novel Carbohydrate Polymer-Based Systems for Precise Drug Delivery in Colon Cancer: Improving Treatment Effectiveness With Intelligent Biodegradable Materials.

Issue Release: 2024

Exploring Hydrogel Nanoparticle Systems for Enhanced Ocular Drug Delivery.

Issue Release: 2024

Trends on Nanomedicines as Novel therapeutics Approach in Targeting Nociceptors for Relieving Pain.

Issue Release: 2024

Leveraging Artificial Intelligence for Better Translation of Fibre-based Pharmaceutical Systems into Real-world Benefits.

Issue Release: 2024

An Assertive Community Intervention to Engage Youth with Opioid Use Disorder and Their Families.

Issue Release: 2024

Physiologically Based Pharmacokinetic Modeling of Ritonavir-Oxycodone Drug Interactions and Its Implication for Dosing Strategy.

Issue Release: 2024

Jail-Based For-Profit Mental Health Providers and Treatment Engagement After Release.

Issue Release: 2024

Lipid-Based Nanoparticles in Delivering Bioactive Compounds for Improving Therapeutic Efficacy.

Issue Release: 2024

Advanced Targeted Drug Delivery of Bioactive Nanomaterials in the Management of Cancer.

Issue Release: 2024

Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo-controlled trial.

Issue Release: 2024

A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: Current status and future perspective over emerging therapy approaches.

Issue Release: 2024

Reductions in World Health Organization risk drinking level are associated with improvements in sleep problems among individuals with alcohol use disorder.

Issue Release: 2024

Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR).

Issue Release: 2024

Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review.

Issue Release: 2024

Microneedles: An Efficient Technique to Increase Transdermal Drug Delivery System.

Issue Release: 2024

NIR-Remote Selectively Triggered Buprenorphine Hydrochloride Release from Microneedle Patches for the Treatment of Neuropathic Pain.

Issue Release: 2024

Poly (hydroxyethylmethacrylate-co-methacryloyl glutamic acid) nanocarrier system for controlled release of levothyroxine.

Issue Release: 2024

Advanced Hydrogels in Breast Cancer Therapy.

Issue Release: 2024

Which Agencies are Involved?

What is the Future of ADE Management?

What is Pharma?

What is Medication Adherence?

How are ADEs Different from Side Effects?

What Types of Medications are Used?

What are the Challenges in Implementing Collaborative Care Models?

What is Geriatric Care in Pharma?

What Are the Challenges in Managing Chronic Conditions?

Why is Generic Competition Important?

Partnered Content Networks

Relevant Topics